Naringenin (NAR),
flavonoid abundant in the genus Citrus, has been reported to interact with the
large-conductance calcium-activated potassium channels (BK). Since activators of
BK channels expressed in cardiac mitochondria trigger protective effects in several models of
myocardial ischemia/reperfusion (I/R), this work aimed to evaluate the potential cardioprotective effects of NAR and the involvement of mitochondrial
BK channels. In an in vivo model of acute
infarct in rats, NAR (100mg/kg i.p.) significantly reduced the
heart injury induced by I/R. This effect was antagonized by the selective BK-blocker
paxilline (PAX). The cardioprotective dose of NAR did not cause significant effects on the blood pressure. In Largendorff-perfused rat hearts submitted to
ischemia/reperfusion, NAR improved the post-ischemic functional parameters (left ventricle developed pressure and dP/dt) with lower extension of myocardial injury. On isolated rat cardiac mitochondria, NAR caused a concentration-dependent depolarization of mitochondrial membrane and caused a trans-membrane flow of
thallium (
potassium-mimetic
cation). Both these effects were antagonized by selective blockers of
BK channels. Furthermore, NAR half-reduced the
calcium accumulation into the matrix of cardiac mitochondria exposed to high
calcium concentrations. In conclusion, NAR exerts anti-ischemic effects through a "pharmacological preconditioning" that it is likely to be mediated, at least in part, by the activation of mitochondrial
BK channels.